Patients aged 18 years with type 2 diabetes treated with metformin ( sulfonylurea ) for at least 3 months with a baseline HbA1c 7.0-10 .0 % ( 53.0-85 .8 mmol/mol ) were randomly assigned ( 2:1 ) via a computer-generated randomisation sequence with a voice response system to receive albiglutide ( 30 mg once a week , n = 504 ) or insulin glargine ( 10 U once a day , n = 241 ) added to current therapy .
